Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome

Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome

BackgroundClinical evidence raises the issues regarding the high risk of adverse events and serious bleeding in East Asian patients receiving standard-dose ticagrelor treatment. We sought to evaluate the association between adverse events and their associations with premature discontinuation of dual...

Full description

Bibliographic Details
Main Authors: Min Gyu Kang, Jong Hwa Ahn, Kyehwan Kim, Jin-Sin Koh, Joeng Rang Park, Seok Jae Hwang, Yongwhi Park, Udaya S. Tantry, Paul A. Gurbel, Jin-Yong Hwang, Young-Hoon Jeong
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
acute coronary syndrome
ticagrelor
bleeding
dyspnea
adherence
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.1053867/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2022.1053867/full

Similar Items